VCTX210

Serial Number 97371557
606

Registration Progress

Application Filed
Apr 20, 2022
Under Examination
May 16, 2023
Approved for Publication
Mar 21, 2023
Published for Opposition
Mar 21, 2023
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: VCTX210
Previous Owner: CRISPR Therapeutics AG
Classes: 042

Trademark Image

VCTX210

Basic Information

Serial Number
97371557
Filing Date
April 20, 2022
Published for Opposition
March 21, 2023
Abandonment Date
June 17, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 17, 2024
Classes
042

Rights Holder

CRISPR Therapeutics AG

99
Address
Baarerstrasse 14
ZUG V8 6300
CH

Ownership History

CRISPR Therapeutics AG

Original Applicant
99
ZUG V8 CH

CRISPR Therapeutics AG

Owner at Publication
99
ZUG V8 CH

Legal Representation

Attorney
Tiffany D. Gehrke

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

15 events
Date Code Type Description Documents
Jul 12, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jun 17, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 30, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 28, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 28, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 28, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 3, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
May 16, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 21, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 21, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 1, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 10, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 7, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 26, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 23, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development

Additional Information

Pseudo Mark
VCTX 210

Classification

International Classes
042